Existing drug may downgrade COVID threat to common cold level — Jerusalem study

https://www.timesofisrael.com/existing-drug-may-downgrade-covid-threat-to-common-cold-level-jerusalem-study/

 

An existing medicine can “downgrade” the danger-level of coronavirus to that of a common cold, a Jerusalem researcher is claiming, after testing it on infected human tissue.

Prof. Yaakov Nahmias says that his research shows that the novel coronavirus is so vicious because it causes lipids to be deposited in the lungs, and that there is a solution to undo the damage: a widely-used anti cholesterol drug called fenofibrate.